Bionix says ReadyHub organizes supplies and preparation for common ear and nose procedures. The system became available through distribution partners Oct. 27.
Bionix Adds ReadyHub Procedure Staging System To OneLight Ecosystem
Browsing Category
General
265 posts
HearUSA Wins Titan Business Award For Patient Care Team Of The Year
HearUSA received a 2026 Titan Business Award for its Patient Care team, citing service work alongside reported gains in appointments and Net Promoter Score.
A Health Update
Craig Hockenberry describes chemotherapy, a March pneumonia hospitalization and signs of nerve recovery after lymphoma treatment.
Massachusetts Home Care Providers Brace For Added Costs Under New State Oversight
A Massachusetts law taking effect Nov. 4 requires caregiver training, background checks and licensing, adding compliance costs for home care providers.
Workforce Shortages And Medicaid Cuts Shift In-Home Care Burden To Families
A Milken Institute publication warns that caregiver shortages and Medicaid cuts could leave families filling gaps in older adults’ home care.
At-Home Virtual Care Startup Kivo Health Secures $10M Series A Financing
Kivo Health raised $10 million in Series A funding to support nationwide expansion of its virtual home-care program, which currently focuses on COPD.
Lawmakers Sound Alarm On CMS’ New Risk-Based Survey
Elizabeth Warren and Mazie Hirono urge CMS to explain its shortened nursing home surveys, facility eligibility rules and trophy designation.
Cardiologist-Prime Minister? LDL Pill Eyed For Diabetes; Second Tricuspid TEER OK’d
A cardiovascular roundup reports a possible diabetes benefit for obicetrapib and FDA approval of Edwards’ Pascal Precision system for tricuspid repair.
16 Home-Based Care Companies Earn Spots On Franchise Times’ Top 400 List
Sixteen home-based care companies appear in Franchise Times’ 2026 ranking, which is based on global systemwide sales. One is ranked outside the Top 400.
Moderna And Merck Say Their mRNA Cancer Vaccine Cut Death, Recurrence By 42%
A Phase 3 trial found lower recurrence-or-death risk with Moderna’s personalized mRNA vaccine plus Keytruda than with Keytruda alone after melanoma surgery.
